Table of contents
Volume 98, Issue 6
Published online 18 March 2008 (1021-1156)
Minireview |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics
Editorial
Further evidence of clinical benefit associated with participation in phase I oncology trials
M Markman
Br J Cancer 98: 1021-1022; doi:10.1038/sj.bjc.6604206
Minireview
Approaches to working in high-dimensional data spaces: gene expression microarrays
Y Wang, D J Miller and R Clarke
Br J Cancer 98: 1023-1028; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604207
Clinical Studies
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
H-T Arkenau, D Olmos, J E Ang, J de Bono, I Judson and S Kaye
Br J Cancer 98: 1029-1033; doi:10.1038/sj.bjc.6604218
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
Y Yamada, M Tahara, T Miya, T Satoh, K Shirao, Y Shimada, A Ohtsu, Y Sasaki and Y Tanigawara
Br J Cancer 98: 1034-1038; advance online publication, March 4, 2008; doi:10.1038/sj.bjc.6604271
Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer: analysis of therapeutic results in134 cases
N Fuwa, T Kodaira, K Furutani, H Tachibana, T Nakamura, R Nakahara, T Tomoda, H Inokuchi and T Daimon
Br J Cancer 98: 1039-1045; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604272
Haemato-oncology and burnout: an Italian survey
C Bressi, S Manenti, M Porcellana, D Cevales, L Farina, I Felicioni, G Meloni, G Milone, I R Miccolis, M Pavanetto, L Pescador, M Poddigue, L Scotti, A Zambon, G Corrao, G Lambertenghi-Deliliers and G Invernizzi
Br J Cancer 98: 1046-1052; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604270
Assessment of the efficacy and toxicity of 131I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours
A C Nwosu, L Jones, J Vora, G J Poston, S Vinjamuri and D M Pritchard
Br J Cancer 98: 1053-1058; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604273
Translational Therapeutics
Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells
A M Sinclair, N Rogers, L Busse, I Archibeque, W Brown, P D Kassner, J E V Watson, G E Arnold, K C Q Nguyen, S Powers and S Elliott
Br J Cancer 98: 1059-1067; doi:10.1038/sj.bjc.6604220
The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers
T Goto, M Takano, J Hirata and H Tsuda
Br J Cancer 98: 1068-1075; advance online publication, March 4, 2008; doi:10.1038/sj.bjc.6604279
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
G E Konecny, N Venkatesan, G Yang, J Dering, C Ginther, R Finn, M Rahmeh, M Schoenberg Fejzo, D Toft, S-W Jiang, D J Slamon and K C Podratz
Br J Cancer 98: 1076-1084; advance online publication, March 11, 2008; doi:10.1038/sj.bjc.6604278
Molecular Diagnostics
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J Henderson, D N Saunders, B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R A Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, D I Quinn, C K W Watts, N F Hacker, S M Henshall and R L Sutherland
Br J Cancer 98: 1085-1093; doi:10.1038/sj.bjc.6604281
Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
P McCall, L K Gemmell, R Mukherjee, J M S Bartlett and J Edwards
Br J Cancer 98: 1094-1101; doi:10.1038/sj.bjc.6604152
Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
J B Tuynman, S M Lagarde, F J W ten Kate, D J Richel and J J B van Lanschot
Br J Cancer 98: 1102-1108; doi:10.1038/sj.bjc.6604251
The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
J Nakano, C Huang, D Liu, D Masuya, H Yokomise, M Ueno, R Haba and S Sumitomo
Br J Cancer 98: 1109-1117; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604253
Genetics and Genomics
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer
D-W Kim, H S Min, K-H Lee, Y J Kim, D-Y Oh, Y K Jeon, S-H Lee, S-A Im, D H Chung, Y T Kim, T-Y Kim, Y-J Bang, S W Sung, J H Kim and D S Heo
Br J Cancer 98: 1118-1124; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604256
HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes
G M Taylor, A Hussain, T J Lightfoot, J M Birch, T O B Eden and M F Greaves on behalf of UKCCS Investigators
Br J Cancer 98: 1125-1131; advance online publication, March 11, 2008; doi:10.1038/sj.bjc.6604257
Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells
D Akinmade, A H Talukder, Y Zhang, W-m Luo, R Kumar and A W Hamburger
Br J Cancer 98: 1132-1140; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604261
Growth arrest-specific gene 6 expression in human breast cancer
O Mc Cormack, W Y Chung, P Fitzpatrick, F Cooke, B Flynn, M Harrison, E Fox, E Gallagher, A Mc Goldrick, P A Dervan, A Mc Cann and M J Kerin
Br J Cancer 98: 1141-1146; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604260
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
H Suzuki, M Toyota, H Caraway, E Gabrielson, T Ohmura, T Fujikane, N Nishikawa, Y Sogabe, M Nojima, T Sonoda, M Mori, K Hirata, K Imai, Y Shinomura, S B Baylin and T Tokino
Br J Cancer 98: 1147-1156; advance online publication, February 19, 2008; doi:10.1038/sj.bjc.6604259
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.